News and Events

Press Releases

Mar 27 2019

Orasis Announces Initiation of Phase 2b Clinical Study of CSF-1 for the Treatment of Presbyopia

Nov 27 2018

Orasis Announces Appointments of Richard L. Lindstrom, Eric D. Donnenfeld, and John Berdahl to its Scientific Advisory Board

Oct 22 2018

Orasis Announces the Appointment of Jeffry Weinhuff as Chairman of the Board of Directors

June 5 2018

Orasis Pharmaceuticals Closes $13 Million Series B Financing

In the News

Apr 8 2019

CEO Elad Kedar Discusses Our Ongoing Phase 2b Clinical Study of CSF-1 and the Eye Drop’s Treatment Effect with Healio

Dec 6 2018

Elad Kedar Featured on the Empowered Patient Podcast

Oct 25 2018

Orasis CEO Elad Kedar Discusses CSF-1 with EyeWorld at the 2018 Ophthalmology Innovation Summit during the Annual AAO Conference

Oct 22 2018

Orasis Announces the Appointment of Jeffry Weinhuff as Chairman of the Board of Directors

June 8 2018

Orasis Completes Financing for Development of Drop to Treat Presbyopia

June 6 2018

Orasis Raises $13 Million to Replace Reading Glasses with Eye Drops

June 6 2018

Farsighted Treatment Co Orasis Pharmaceuticals Raises $13M

June 5 2018

Orasis Pharmaceuticals Closes $13M Series B Financing